Torrent Pharmaceuticals Limited — Updates, 20-05-2025: Press Release

Torrent Pharma has announced a board meeting to approve the financial results for the quarter and half-year. Q4 revenue grew 8% YoY to Rs 2,959 Cr, with operating EBITDA rising 9% to Rs 964 Cr (adjusted Rs 981 Cr, 11% growth) and net profit up 11% to Rs 498 Cr. India led growth with 12% revenue increase, while Brazil posted 5% constant currency growth despite currency challenges. Germany and the US showed steady double-digit growth. R&D spend was 5.1% of revenues. Aman Mehta will be MD from August 1, 2025. A final dividend of Rs 6/share is proposed.